MUNRO CLINICAL PROJECTS LTD — 09839333, Knutsfo , Great Britain. Free business summary

Express analysis of risk factors (100%)

Wait a minute to know everything about this company...

Sign up to see

Check if company has connections with Financial Industrial Group from Russia

Sign up to see

Check if company has connections with business in Russia

Sign up to see

Check if company has connections with the Politically Exposed Person of Russia

Sign up to see

Check if company’s officer has connections with Russia

Sign up to see

Check if company’s officer has connections with Belarus

Sign up to see

Check if company’s PSC has connections with Russia

Sign up to see

Check if company’s PSC has connections with Belarus

soon

Sanctions

Actual on 01.11.2024

Company name	MUNRO CLINICAL PROJECTS LTD copy copied
Company number	09839333 copy copied
Company status	Active copy copied
Company type	Private Limited Company copy copied
Incorporated on	Friday, 23 October 2015 copy copied
Accounts	Actual Next accounts made up to 31.10.2024 due by 31.07.2025 Last accounts made up to 31.10.2023
Confirmation statement	Actual Next statement date Wednesday, 22 October 2025 due by Tuesday, 04 November 2025 Last statement dated Tuesday, 22 October 2024
Nature of business (SIC)	70229 - Management consultancy activities other than financial management copy copied
Registered office address	7 GRASSFIELD WAY, CHESHIRE, ENGLAND, KNUTSFORD, WA16 9AF copy copied

Officers

(as of 16.08.2022)

MATHEWSON, Alastair

Status:	Active
Appointed on:	Friday, 23 October 2015
Correspondence address:	7 Grassfield Way, Knutsford, England, Cheshire, WA16 9AF
Nationality:	British
Date of birth:	January 1977
Role:	Director
Occupation:	Director
Country of residence:	England

Person with significant control

(as of 25.08.2023)

Alastair Mathewson

Status:	Active
Notified on:	Thursday, 30 June 2016
Correspondence address:	7 Grassfield Way, Knutsford, England, Cheshire, WA16 9AF
Nationality:	British
Date of birth:	January 1977
Legal form:	Individual Person With Significant Control
Country of residence:	England
Nature of control:	Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent